MedMen Enterprises Inc. MMNFF MMEN appointed Ellen Deutsch as CEO, effective immediately, and Amit Pandey as CFO, effective July 24th. Deutsch succeeds interim CEO Edward Record, who will now continue as a non-executive member of MedMen’s board of directors. Deutsch has also been appointed to the company’s board of directors, increasing the size of the board of directors to six.
“We thank Ed for his tenure as interim CEO and success initiating MedMen’s turnaround and returning the company to positive adjusted EBITDA. We look forward to his continued presence as a member of our board of directors,” stated Michael Serruya, MedMen’s chairman. “Ellen’s leadership and strong operational experience in the public cannabis sector will prove invaluable as we complete our restructuring plan and transition into a new phase of growth for the company.”
Deutsch brings operational, marketing, and financial experience and expertise in the cannabis and CPG industries, having most recently served as senior vice president of market development and shared services at Acreage Holdings ACRHF ACRDF. Before joining Acreage, Deutsch served as executive vice president/chief operating officer at Stem Holdings, Inc STMH.
“MedMen is one of the most recognizable brand names in cannabis and has a loyal base of consumers who trust it to deliver excellence in product and customer experience,” stated Deutsch. “It is an exciting challenge to lead its team of dedicated professionals to deliver value for all stakeholders as we enter a new phase of the company’s strategic vision and implement plans to strengthen our core.”
Pandey joins MedMen with a financial background in private and public markets spanning cannabis, consumer packaged goods (CPG), and fintech. He previously served as executive vice president and interim chief financial officer of finance at Clever Leaves International, Inc CLVR.
“Amit’s considerable background and experience in both the public and private capital markets in cannabis and CPG sectors will be critical to MedMen’s short-term restructuring and long-term growth,” stated Serruya. “With the addition of Ellen and Amit, MedMen has completed the buildout of its go-forward management team.”
Benzinga Cannabis Capital Conference
The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Photo by Esteban López on Unsplash
Related News
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!